Five Main Drivers in Achieving Our Goals

Scientific approach
StrongCORE SCIENTIFIC

Scientific approach
to help shaping any aspect of your clinical development

Quick patient access
ACCELEROUTE

Robust recruitment
methodology for
quick patient access

Fine-tuned processes
PACE

High standards in project methodology with
fine-tuned processes

High quality results
QUALITY HEALTH CHECK

Risked based approach
with preventive QA

Integrated Clinical Development technology
WIDESCOPE INTELLIGENCE

Use of state-of-the-art & integrated clinical development technology

Align Our Expertise With Your Needs

Pioneers in Biosimilar Development

Pioneers in Biosimilar Development

 

We have in-depth experience and expertise to accelerate and perfectly handle the complexity of any biosimilar study. Work together with the pioneers in biosimilars!

Biosimilar development

Studies on special patient populations

Studies on Special Patient Populations

 

Accelsiors is a specialist of clinical trials in special study populations for numerous indications. Our expertise is especially outstanding in pediatric, women’s health, rare diseases and age-group-targeted studies.

Special patient populations

Innovative medicine development

Innovative Medicine Development

Take advantage of our broad experience in the field of innovative drug development from small molecules through complex therapeutic proteins to nanotechnology-formulated development.

Innovative development

Where Do You Need Us?

Accelsiors operates on a global scale utilizing local expertise to deliver studies within the agreed budget and timelines, meeting the utmost quality expectations. Anywhere you need us…

How Can We Support Your Pipeline?

We are the only resource you need for your clinical trial. We provide end-to-end solution right from inception of study design to site selection to product approval.

Full-Service CRO Solutions

Latest NEWS

News
 14 May, 2019

6th MICROBIOME R&D AND BUSINESS COLLABORATION FORUM PARTICIPATION

Accelsiors is delighted to announce participation at the 6th Microbiome R&D & Business Collaboration Forum, taking place on 20-22 May in Rotterdam, with a dedicated focus on R&D and business collaborations in microbiota research, probiotics, health and disease.

News
 07 May, 2019

ACCELSIORS TO ATTEND SWISS BIOTECH DAY 2019

Accelsiors CRO is pleased to announce participation at the Swiss Biotech Day 2019 (SBD), taking place on May 7, 2019 in Basel, Switzerland. We are proud to be part of this leading and influential meeting dedicated to demonstrate the power and potential of the Swiss biotech hub.